Proteins Associated with Disease and Clinical Course in Pancreas Cancer: A Proteomic Analysis of Plasma in Surgical Patients
- 8 August 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 5 (9), 2169-2176
- https://doi.org/10.1021/pr0600374
Abstract
New biomarkers for pancreas cancer are needed to improve its detection and management. We surveyed the plasma of patients undergoing surgical resection to identify proteins which change in abundance after complete resection of tumor. Using longitudinally collected specimens from surgical patients, we control for normal inter-individual variation which can confound cross-sectional analysis. Recent refinements in two-dimensional gel electrophoresis allowed us to quantify changes in low abundance plasma proteins with precision. To circumvent the traditional limitations of image analysis in comparing two-dimensional gels, we used fluorometric two-dimensional difference gel electrophoresis to resolve the proteins from pre- and post-surgical plasma from each patient on one physical gel. Furthermore, we increased the ability of our assay to detect low-abundance proteins by depleting the plasma of 12 high-abundance proteins with a multi-affinity column. Informative protein spots from 20 plasma samples across 10 patients were submitted for identification with mass-spectrometry. We identified a group of proteins which change consistently in plasma following complete resection of pancreas tumor. Furthermore, we identified proteins which correlate with post-surgical rapid recurrence of disease. With further identification and validation, the candidate biomarkers which we identify in this study may prove to be useful in the diagnosis, management and prognostication of patients with pancreas cancer. Keywords: pancreas cancer • biomarkers • proteomics • fluorescence two-dimensional difference gel electrophoresisKeywords
This publication has 18 references indexed in Scilit:
- Fibrinogen γ Overexpression in Pancreatic Cancer Identified by Large-scale Proteomic Analysis of Serum SamplesCancer Research, 2006
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Functional genomics studied by proteomicsBioEssays, 2004
- Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinomaBritish Journal of Surgery, 2004
- Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissectionOncogene, 2004
- Application of laser capture microdissection combined with two‐dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinomaProteomics, 2003
- A novel experimental design for comparative two‐dimensional gel analysis: Two‐dimensional difference gel electrophoresis incorporating a pooled internal standardProteomics, 2003
- The Human Plasma ProteomeMolecular & Cellular Proteomics, 2002
- Expression profiling of microdissected pancreatic adenocarcinomasOncogene, 2002
- Difference gel electrophoresis. A single gel method for detecting changes in protein extractsElectrophoresis, 1997